A terrific Wednesday to you as stocks slip as China data compounds recession fear.
A wonderful Thursday to you as global stocks headed for the highest level in more than two months.
A magnificent Monday to you as investors wary of risks following deaths from virus in China.
A terrific Thursday to you as Asian stocks mostly down as China tech sold off.
A terrific Friday to you as stocks surge in Asia to xxtend post-CPI rally.
A great Tuesday to you as investors are watching for risk of gridlock in US government.
Global stocks trimmed a weekly loss as Chinese tech shares rebounded more than 10%, helping offset s...
Traders immediately raised the market-implied peak in interest rates for next year.
A terrific Wednesday to you as equities pared gains ahead of the Federal Reserve’s policy meeting.
A wonderful Tuesday to you as investors awaited the Federal Reserve’s policy meeting.
The yen fell against most of its major peers, with economists expecting the Fed to raise rates by an...
A magnificent Friday to you as stocks retreat in cautious end to turbulent month.
A wonderful Thursday to you with investors positioning for less aggressive rate hikes as earnings an...
A great Tuesday to you as global stocks held a small advance.
A wonderful Monday to you as investors await the next batch of earnings from some of the world’s b...
A magnificent Friday to you as stocks climb in options day as bond rout fades.
A generally strong start to the third-quarter earnings season has bolstered sentiment toward equitie...
A magnificent Wednesday to you as corporate-earnings season in focus across equity markets.
A wonderful Tuesday to you as stocks extend their rally as investor angst eases.
A great Monday to you as investors assess defiant speech from China’s President Xi.
A wonderful Friday to you as Asian stocks climb in wild ride after CPI data.
Stocks steadied as investors put aside concerns about the worsening global outlook, while UK bonds t...
A terrific Tuesday to you as Fed officials offer cautious note in push to quell price gains.
A wonderful Monday to you as Fed’s campaign to quell inflation threatens to stymie growth.
A wonderful Tuesday to you as a rally in global markets extended into a second day.
A magnificent Monday to you as global stocks fell to a two-year low amid concern hawkish policies by...
Investors are grappling with threats posed by discordant moves from central banks over the past few ...
Investors are contending with threats posed by discordant moves from central banks over the past few...
Important Risk Information
The information provided on this site is for informational purposes only. It is not to be construed as investment advice or a recommendation or offer to buy or sell any security. Prospective clients should always obtain and read an up-to-date product and/or services description or prospectus before deciding whether to invest. Any views expressed herein are those of Novum Alpha SPC (“the Company”) are based on available information, and are subject to change without notice. Novum Alpha SPC is a registered mutual fund under Section 4(3) of The Mutual Funds Act (2021 revision to carry on mutual fund business in or from the Cayman Islands, subject to the provisions of the aforementioned Act with Registration Number: 1890405.
There are no guarantees regarding the achievement of investment objectives, target returns, or measurements such as alpha, tracking error, asset weightings and other information ratios. The views and strategies described may not be suitable for all clients. The Company does not provide tax or legal advice. Prospective subscribers should consult with a tax or legal advisor before making any investment decision. Investing in any investment product entails risks and there can be no assurance that the Company avoid incurring losses or achieve any of a prospective subscriber’s investment goals.
Performance quoted represents past performance, which is no guarantee of future results. Investment and principal value will fluctuate, so you may have a gain or loss when assets are sold. Current performance may be higher or lower than that quoted product’s expenses and other liabilities, and such product may be unable to meet its investment objective